Sleep, insomnia and mental health

Abstract

Summary While sleep serves important regulatory functions for mental health, sleep disturbances, in particular insomnia, may favour a state of allostatic overload impairing brain neuroplasticity and stress immune pathways, hence contributing to mental disorders. In this framework, the aim of this work was to link current understanding about insomnia mechanisms with current knowledge about mental health dysregulatory mechanisms. The focus of the present work was on mood, anxiety, and psychotic disorders, which represent important challenges in clinical practice. Literature searches were conducted on clinical, neurobiological, and therapeutic implications for insomnia comorbid with these mental disorders. Given the complexity and heterogeneity of the existing literature, we ended up with a narrative review. Insomnia may play an important role as a risk factor, a comorbid condition and transdiagnostic symptom for many mental disorders including mood/anxiety disorders and schizophrenia. Insomnia may also play a role as a marker of disrupted neuroplasticity contributing to dysregulation of different neurobiological mechanisms involved in these different mental conditions. In this framework, insomnia treatment may not only foster normal sleep processes but also the stress system, neuroinflammation and brain plasticity. Insomnia treatment may play an important preventive and neuroprotective role with cognitive behavioural therapy for insomnia being the treatment with important new evidence of efficacy for insomnia, psychopathology, and indices of disrupted neuroplasticity. On the other hand, pharmacological pathways for insomnia treatment in these mental conditions are still not well defined. Therapeutic options acting on melatonergic systems and new therapeutic options acting on orexinergic systems may represents interesting pathways of interventions that may open new windows on insomnia treatment in mental disorders.

Use of prescription benzodiazepines and related drugs in family caregivers: a nation-wide register-based study

“…Several studies have also found more self-reported mental health problems in caregivers compared with non-caregivers [9,10] and caregivers appear to use more antidepressants than non-caregivers [14]. Insomnia and other mental health problems are often intertwined [15] and may follow from chronic stress [16,17], which has been reported in previous caregiver studies especially in high-intensity caregivers [9,18]. Caregivers included in the present study, i.e.…”

The Relationship between Anxiety, Subjective and Objective Sleep, Chronotype and Circadian Rhythms with Depressive Symptoms in Insomnia Disorder

“…The psychopathology of depression is complex and multifactorial with genetic and environmental drivers involved in the development. However, insomnia can precede the onset of symptoms and coexist as a comorbid condition, and is often a key feature of the clinical symptoms of depression [ 5 ].…”

Daridorexant for the Treatment of Insomnia

“…18,19 The current literature utilizes different approaches to describe the manifestations of insomnia such as the neurobiological, cognitive, behavioral, and emotional models. [19][20][21] Regardless of the model, there is a consensus that insomnia is the result of a dysregulation of brain centers containing the circadian rhythm and homeostatic processes that control sleep and wakefulness. 5 The ascending reticular activation system (ARAS) influences wakefulness while the ventrolateral preoptic region (VLPR) drives to sleep.…”